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Abstract
Disruption of gene regulation by sequence variation in non-coding regions of the genome is
now recognised as a significant cause of human disease and disease susceptibility. Se-
quence variants in cis-regulatory elements (CREs), the primary determinants of spatio-tem-
poral gene regulation, can alter transcription factor binding sites. While technological
advances have led to easy identification of disease-associated CRE variants, robust meth-
ods for discerning functional CRE variants from background variation are lacking. Here we
describe an efficient dual-colour reporter transgenesis approach in zebrafish, simultaneous-
ly allowing detailed in vivo comparison of spatio-temporal differences in regulatory activity
between putative CRE variants and assessment of altered transcription factor binding po-
tential of the variant. We validate the method on known disease-associated elements regu-
lating SHH, PAX6 and IRF6 and subsequently characterise novel, ultra-long-range SOX9
enhancers implicated in the craniofacial abnormality Pierre Robin Sequence. The method
provides a highly cost-effective, fast and robust approach for simultaneously unravelling in
a single assay whether, where and when in embryonic development a disease-associated
CRE-variant is affecting its regulatory function.
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Author Summary
Cis-regulatory elements (CREs) play a vital role in gene regulation by providing spatial
and temporal specificity to the expression of their target genes. Understanding how these
regions of the genome work is of vital importance for human health as it has been demon-
strated that genetic changes in these regions can result in incorrect gene expression, lead-
ing to a variety of human diseases. Functional characterization of putative CREs and the
effects of mutations on their activity is currently a major bottleneck in many studies to-
wards understanding the causes and mechanisms of disease and disease susceptibility. We
describe a robust in-vivo approach using dual-colour reporter transgenesis in zebrafish for
unambiguous assessment of the effects of disease-associated CRE mutations on CRE activ-
ity during the entire time-course of embryonic development. The highly efficient, cost-ef-
fective and modular design of the assay allows rapid analysis of several CRE-variants in
parallel. We illustrate the robustness of our approach using examples of CRE-variants as-
sociated with a broad spectrum of genetic diseases including brain, limb, eye and jaw dis-
orders. In a single assay the method can address where and when in development the CRE
variant affects its activity, what potential target genes are misregulated by the change and
what upstream trans-acting factors are likely to mediate this effect.
Introduction
Cis-regulatory elements (CREs) such as enhancers are vital functional regions of the genome
which determine where, when and at what levels their target genes will be expressed [1]. In
keeping with their crucial role in the control of gene expression, CRE aberrations have been
implicated as the cause of a variety of human diseases, genetic trait differences and predispo-
sition to common diseases [2–3]. Modern approaches, such as next generation sequencing,
now allow rapid determination of genetic variation between individuals to single nucleotide
resolution. In contrast to the advancement offered by these high throughput methods for
identification of sequence polymorphisms, progress towards an understanding of their pre-
cise role in disease etiology is hampered by a shortage of efficient methods for the functional
characterization of observed variants. Identifying exactly which of the non-coding SNPs in a
haplotype block have a regulatory function, and in what physiological context, has been com-
plicated by some of the characteristic features of CREs: They can be located at very large dis-
tances (in some cases over a mega base) from their target genes; they can reside in gene
deserts, or within the introns of- or even beyond- neighboring genes, making the prediction
of their target genes difficult. Unlike coding mutations, the effect of non-coding sequence
variation is difficult to predict. Moreover, CRE activities are often tissue- and stage-specific
and highly dependent on the precise combination and stoichiometry of tissue-specific tran-
scription factors [4]. The in vivo relevance, at the level of the whole organism, of approaches
that utilize conventional assays in cell lines to test the effect of a disease-associated CRE vari-
ant is therefore highly questionable. The lack of efficient high-throughput and physiologically
relevant assays for functional validation of tissue- and developmental-stage-specific CREs
and identification of their target genes thus poses a real bottleneck in translating human non-
coding variation into better understanding of disease mechanisms.
In our search for an efficient approach for characterizing regulatory variation in a verte-
brate model system, we developed a versatile, streamlined assay pipeline using zebrafish
(Danio rerio). Zebrafish embryos are transparent and develop rapidly and outside the mother,
making it feasible to visualize specific tagged cell types in the living animal. They are well
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suited for transgenic manipulation since it is relatively easy to collect and inject large numbers
of fertilized eggs [5]. These features make transgenic zebrafish a useful model for the charac-
terisation of putative tissue-specific CREs in particular over the time-course of vertebrate de-
velopment but also in adult tissues [6]. The use of multiple fluorescent reporters enables
direct comparison between different cis-elements or different variants of the same element in
the same cells of the same animal.
To determine the performance of the system, we tested a set of known disease-associated
CREs in dual colour zebrafish reporter transgenics and demonstrate that the method is effec-
tive in revealing differences in functional output between variants in agreement with previ-
ously reported in mouse studies of these elements. We then applied the method to investigate
a set of novel putative CREs with potential disease-associated variants in the genomic region
of the SOX9 gene. These variant elements, located at very long distances from SOX9, in the
large gene desert between SOX9 and KCNJ2, were identified based on their potential involve-
ment in the congenital craniofacial malformation Pierre Robin Sequence (PRS) [7]. Consis-
tent with their possible role in PRS aetiology, we show that these elements drive specific
expression patterns in the craniofacial region of zebrafish and we reveal that the variant en-
hancer alleles found in the PRS patients have a variety of functional effects including: com-
plete loss of activity; partial, tissue-specific loss of enhancer activity; and failure to maintain
enhancer activity through development.
Results
Development of an efficient assay pipeline for rapid assessment of the
functional relevance of sequence variants in potential cis-regulatory
elements
Connecting a sequence variant in a non-coding genomic region to disease aetiology in the pa-
tient in whom the variant was detected, is currently a major bottleneck in human genetics.
To efficiently assess genomic regions harbouring putative disease associated sequence vari-
ants, we designed a versatile, robust and cost-effective assay pipeline which combines Gateway
cloning technology and Tol2-mediated transgenesis to rapidly generate multiple dual-fluores-
cence reporter-transgenic zebrafish lines. The assay enables direct in vivo comparisons of the
spatial and temporal activities of wild-type (Wt) and putative SNP or mutation (Mut) bearing
CREs within the same animal by confocal imaging (Fig 1). The first step involves cloning of the
genomic fragment(s) containing the putative cis-regulatory element using fast and highly-effi-
cient Gateway cloning technology (Fig 1A and 1B). In cases where the disease involved is due
to haplo-insufficiency of target gene expression, we were able to clone both wild-type and mu-
tant fragments by PCR from heterozygous patient DNA. For fragments associated with quanti-
tative traits, the phenotypic extremes of the trait will mostly segregate with homozygosity of
the variant sequence. Nevertheless one can clone both variant fragments from an intermediate
heterozygous individual or use a mix of the DNA of two homozygous extremes for single-step
PCR cloning. Where patient DNA is not available the variant can be made via site-directed mu-
tagenesis. The fragments of interest are inserted into an appropriate Gateway entry vector by
inclusion of attB recombination sequences into the PCR cloning primers (Fig 1A and 1B). Se-
quencing is used to confirm the presence of each allele of the element of interest in the resulting
clones and to exclude the presence of additional confounding mutations introduced during
cloning. Both versions of the CRE are then recombined with different flavours of fluorescent
reporter cassettes by a multi-gateway reaction into a destination vector containing Tol2 trans-
poson sites for efficient zebrafish transgenic production (Fig 1B) [8]. The use of Gateway clon-
ing vectors allows high-efficiency, rapid construction of enhancer-reporter constructs. This
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Fig 1. Schematic representation of the assay pipeline for in vivo characterisation of disease-associated cis-regulatory variants by dual-
fluorescence reporter transgenic analysis in zebrafish. (A-B) The CRE bearing the disease-associated variant is amplified using genomic DNA, from the
variant carrier individual. Both alleles of potential functional elements are cloned into a Gateway entry vector and recombined in a Multi-Gateway reaction
with a reporter cassette of choice and a Tol2 inverted repeats containing construct to create the Cis-element-Reporter cassette flanked by Tol2 sites. (C) Co-
injection of reporter vectors containing wild-type (Wt) and mutant (Mut) versions of the putative enhancer with Tol2 transposase-encoding RNA into early
zebrafish embryos results in independent integration of the reporter cassettes. Transgenic founder fish (F0) are bred to establish transgenic lines. Expression
patterns are examined in fish of F1 or later generations. Differences between wild-type and mutant elements can be compared directly in the same fish using
the GFP and mCherry fluorescent reporters. (D) Disease-causing variants affecting a predicted transcription factor binding site can be validated by
knockdown of the binding protein using morpholinos directed to the transacting factor.
doi:10.1371/journal.pgen.1005193.g001
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feature is especially advantageous for scaled-up testing of the functional relevance of a large
number of putative CRE-variants identified in disease-association studies. Reporter cassettes
encoding eGFP or mCherry driven from a gata2 minimal promoter were generally used, but
can easily be exchanged for other promoter-reporter combinations. To exclude bias in detec-
tion levels between the eGFP and mCherry fluorophores we have conducted reporter cassette
swaps for some of the elements, and found highly similar outcomes in all cases.
Both Tol2 constructs (bearing the Wt and Mut versions of the CRE) were co-injected
with Tol2 mRNA into 1–2 cell stage zebrafish embryos (Fig 1C). Since many of the injected
embryos (F0) show a variable extent of patchiness within their (mostly tissue-specific) ex-
pression patterns due to cellular mosaicism,the F0 founders are routinely grown to adult-
hood to generate stable lines. In our hands approximately 20 percent of injected embryos
produce stable, dual reporter-expressing founder lines, thus yielding 7–10 independent
founder lines in a single round of injection (of ~50 oocytes). The F0’s (we usually proceed
with 3 to 5 independent F0’s per CRE) are then screened for reporter gene expression driven
by the Wt and Mut versions of the CRE by out-crossing with non-transgenic fish of a stan-
dard laboratory strain. Tissue-specific CRE activities of the Wt and Mut alleles are scored in
F1 embryos obtained from at least 3–5 independent F0 lines to eliminate any bias arising
from the influence of site of integration of the transgene on the CRE activity. Tissues where
CRE (Wt or Mut)-driven reporter gene expression is consistently observed in the progeny of
>75% of independent F0 lines are scored as constituent parts of the activity domain of the
CRE being analysed (S1 Table and S1 Fig). The expression pattern driven by the Wt and Mut
versions of the CRE are visualised by confocal laser-scanning microscopy and compared un-
ambiguously in the same animal through the entire time course of development of the F1
embryos (1–5dpf). Tissues and cell-types where the activities of the WT and Mut CREs
completely overlap are observed as yellow in the merge channel, while the differences in
CRE activities are revealed as green or red fluorescence. The assay thus provides complete
and detailed spatial and temporal information about functional activity of the CRE and si-
multaneously reveals where and when in embryonic development this activity is affected by
the presence of the disease-associated mutation. The combination of rapid cloning, high-effi-
ciency, cost-effective transgenesis and dual-colour imaging makes the assay a very effective
approach for rapid in vivo functional assessment of disease-implicated CRE-variants. Fur-
thermore, in the case of novel CREs for which the target gene has not yet been established,
comparisons can be made with the expression patterns of the zebrafish orthologs of potential
candidates genes using RNA in situ hybridisation. It should however be kept in mind that
subtle differences may exist between the expression of the zebrafish ortholog(s) and the
human (or other species) gene the CRE is thought to regulate.
The most common established mechanism by which disease-associated sequence changes
affect CRE function is by alteration or disruption of binding sites for tissue-specific transcrip-
tion factors. The final part of our assay pipeline contains a convenient method for testing the
validity of predicted disruptions of Transcription Factor Binding Sites (TFBS) by the disease-
associated point-mutations (Fig 1D). F1 fish of selected reporter lines are bred to obtain dual-
transgenic F2 embryos which are injected with morpholinos against the transcription factor
whose binding is predicted to be affected by the mutation. The injected embryos are subse-
quently analysed for the effects of knock-down of the transcription factor on the expression
pattern driven by the WT version of the CRE. The presence of the Mut CRE driving a different
fluorophore within the same embryo allows unambiguous comparison of the effects produced
by the transcription factor knock-down on the WT allele activity versus the effect of the altered
binding site of the transcription factor as seen by the Mut-allele activity.
In Vivo Functional Analysis of Disease-Linked Cis-regulatory Variants
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Establishing robustness of the assay pipeline using known disease-
associated enhancer variants
To test the robustness of our dual-fluorescence reporter transgenic assays we selected four dis-
ease-associated CREs from the literature for which point-mutations had been firmly estab-
lished as the cause of human monogenic disease (Table 1).
The SBE2 element is a CRE that controls SHH (sonic hedgehog) expression in the develop-
ing forebrain (Fig 2A). A point mutation (C>T) in SBE2 was reported in a patient with holo-
prosencephaly, and in mouse transgenic experiments the mutation was shown to abrogate the
activity of SBE2 in the rostral hypothalamus [9]. We tested the humanWt(C) and Mut(T)
SBE2 alleles in our dual-colour zebrafish assay. Despite the low level of sequence conservation
of human SBE2 in the zebrafish genome (Fig 2A), we observed activity of the Wt human SBE2
element in the developing rostral and caudal hypothalamus of transgenic fish. Simultaneous
analysis of the holoprosencephaly-associated Mut allele in the same embryos unambiguously
demonstrated the partial loss of activity in the rostral hypothalamus (Fig 2B). Dye-swap experi-
ments between the Wt(C) and Mut(T) SBE2 alleles consistently showed loss of expression in
rostral hypothalamus from the Mut(T) allele irrespective of the linked reporter fluorophore
used, excluding any bias in detection levels between the GFP and mCherry fluorophores (Fig
2B). The Wt(C) allele also showed reporter signal in the rostral forebrain at 96hpf, which was
lost when the Mut(T) allele was used (Fig 2B). This observation contrasts with the study of the
mouse SBE2 element [9], where no activity of the enhancer was observed outside the hypothal-
amus. Some species-specific differences in CRE activity can thus be observed while employing
these CRE-reporter assays. The reporter gene expression pattern driven by the Wt(C) SBE2 al-
lele in the rostral and caudal hypothalamus significantly overlapped with the endogenous ex-
pression pattern of its target gene shha in the developing zebrafish embryo (Fig 2C). The C>T
change in the SBE2 CRE had been demonstrated to occur in a SIX3 TFBS and disrupts SIX3
binding [9–10]. We knocked down Six3 by injecting morpholinos against Six3a and Six3b [11]
into F2 transgenic embryos and the extent of Six3 depletion was assessed by immunoblot (S2
Fig). We observed that reporter expression driven by the Shh-SBE2 CREWt(C) allele shrunk
to a more restricted domain in the caudal hypothalamus to match with the expression driven
by the Mut(T) allele (Fig 2D). The expression domain driven by the Mut(T) allele, bearing a
disrupted Six3 binding site, was not altered upon Six3 knockdown. Expression driven by both
the alleles was unaffected upon injections of control morpholinos (Fig 2D). Our assay therefore
demonstrates or confirms that the C>T mutation compromised Shh-SBE2 function by abro-
gating Six3 binding.
SHH encodes a powerful morphogen whose expression at different times and places during
development is controlled by multiple CREs distributed over a 1Mb regulatory domain. The
most distant of these—the ZRS (ZPA regulatory sequence)—controls expression that is re-
stricted to the posterior mesenchyme of the distal limb bud (Fig 3A). A number of different
point-mutations in the ZRS have been reported in patients with pre-axial polydactyly [12].
Among these, the Cuban mutation, a G>A change, has been shown to cause strong ectopic re-
porter expression in the anterior part of the limb-bud in transgenic mice [13]. Therefore this
Table 1. Known disease-associated CRE variants studied.
Element name (reference) Target gene (HGNC no.) Disease/trait (OMIM no.) Expression pattern Distance from promoter
SHH-SBE2 [9] SHH (10848) Holoprosencephaly (142945) Forebrain 460 kb
ZRS [13] SHH (10848) Polydactyly (174500) Limb buds 980 kb
IRF6-MCS-9.7 [15] IRF6 (6121) Orofacial clefting (608864) Craniofacial 9.7 kb
doi:10.1371/journal.pgen.1005193.t001
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Fig 2. Dual-fluorescence transgenic analysis of a SHH enhancer SBE2 where a C>T change in a Six3 binding site has been identified in a patient
with holoprosencephaly. (A) Regulatory landscape of SHH, depicting the location of the SBE2 enhancer. The sequence conservation plot on the right
shows the low level of sequence conservation for SBE2 in the zebrafish genome. (B) SHH-SBE2 enhancer-driven F1 reporter transgenics. The wild-type
allele Wt(C) drives expression in the rostral and caudal hypothalamus (long green or red bar) independent of the associated fluorophore (eGFP or mCherry).
Expression from the mutant allele, Mut(T), is retained in the caudal hypothalamus (short green or red bar) but lost in the rostral hypothalamus (short green or
red bar). Additional expression of the SBE2Wt(C) allele in the rostral forebrain of later stage (96hpf) zebrafish embryos is also lost by the Mut(T) allele. (C)
RNA in situ hybridisation analysis of shha and shhb expression at 48hpf and 96hpf of zebrafish embryonic development. The reporter gene expression
In Vivo Functional Analysis of Disease-Linked Cis-regulatory Variants
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mutation appears to represent a gain of function in a CRE, rather than a loss of function as
demonstrated for the SBE2. To test whether our assay can detect this altered ZRS function, we
assayed the activity of the Wt(G) and Mut (A) human ZRS alleles. The Wt(G) allele drove ex-
pression of both eGFP and mCherry reporters in the zone of polarising activity (ZPA) of the
developing pectoral fins (S3 Fig), at the same site where zebrafish both shha and shhb expres-
sion is normally seen (Fig 3Ac). This is consistent with the expression pattern driven by this
CRE in mouse experiments [13]. We observed a mutation-driven expansion of reporter expres-
sion at 72 hpf, comparable to the changes reported in the mouse forelimb bud. By 96 hpf the
additional domain of mutant ZRS-eGFP expression has become stronger and more obvious,
strongly lighting up the anterior edge of the growing pectoral fin (Fig 3Ab). Thus our assay is
able to detect a gain of function in CRE activity.
We next analysed a CRE from another developmental gene locus. The SIMO element regu-
lates the expression of PAX6 in the eye, and we have previously demonstrated that a point mu-
tation in this CRE can cause the congenital eye malformation aniridia by disrupting an
autoregulatory PAX6 binding site in the element [14]. Using dye-swap experiments we demon-
strated that, in contrast to the Wt(G) element, and irrespective of the fluorophore used, the
Mut(T) allele consistently fails to drive reporter gene expression in the developing lens (Fig
3Bb). This observation was in complete agreement with the results obtained when the Wt and
Mut elements were tested using mouse transgenic experiments [14]. The reporter gene expres-
sion driven by the Wt(G) allele also overlapped with the expression pattern of the zebrafish ho-
molog of its target gene (pax6a) (Fig 3Bc).
The final known disease-associated non-coding variant we studied was a well-established
polymorphic change associated with cleft lip, in an upstream regulatory element controlling
the expression of Interferon Regulatory Factor 6 (IRF6) [15]. The minor allele mutant site (des-
ignated as SNP rs642961) has been shown to disrupt a TFAP2A binding site, but no compara-
tive analysis had been carried out previously to show how the wild-type and variant enhancer
functions differ [15]. The Wt(G) allele of this element drives expression in the first pharyngeal
arch and in the ethmoid plate of transgenic fish, both sites where IRF6 is thought to play a key
role during oral and palate development [16]. We found that expression driven by the Mut(A)
transgene was maintained in the pharyngeal arch, but expression in the ethmoid plate was
abolished (Fig 4B). Endogenous expression of zebrafish irf6 was also detected in both the first
pharyngeal arc and the ethmoid plate (Fig 4C). Our assay is thus able to demonstrate unambig-
uously the in vivo effect of a common disease-associated variant on enhancer activity.
Functional characterisation of novel long-range CREs from the SOX9
locus carrying PRS-associated private sequence variants
Having tested our assay system with a spectrum of previously described CREs implicated in
disease, we embarked on the assessment of a set of novel predicted regulatory elements from
the 1.5 Mb “gene desert” upstream of SOX9, in the interval between SOX9 and KCNJ2 (Fig 5A).
Overlapping deletions associated with isolated Pierre Robin Sequence (PRS) were identified in
the region 1.2–1.5 Mb upstream of SOX9, highlighting a sub-region particularly associated
with PRS within the larger intergenic domain [7]. PRS is a craniofacial disorder characterized
pattern driven byWt(C) allele significantly overlaps with the shha expression domain in the hypothalamus. (D)Morpholino knock-down of Six3 in SHH-SBE2
transgenic embryos mimics the effect of the Six3 binding site mutation in SBE2. F2 embryos bearing both SHH-SBE2Wt(C) and Mut(T) alleles injected with
either control morpholino (Control MO) or morpholino against both six3A and six3B (six3 AMO). Upon knockdown of six3, the hypothalamus expression
driven by theWt allele shrinks to overlap completely with the expression driven by the mutant allele (bearing a mutant six3 binding site). Wt: wild-type; Mut:
mutant; hpf: hours post fertilization; MO: morpholino, RH: Rostral hypothalamus; CH: Caudal hypothalamus; rFB: Rostral forebrain.
doi:10.1371/journal.pgen.1005193.g002
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Fig 3. Dual-fluorescence transgenic analysis of established CREs with disease-associated point mutations. (A) SHH-ZRS. (a) The regulatory
landscape of SHH, depicting the location of ZRS enhancer. The conservation plot on the left shows the low level of sequence conservation for ZRS in the
zebrafish genome. (b) SHH-ZRS enhancer-driven reporter expression is shown at 72 hpf and 96 hpf. The top row shows the Wt(G) allele driving both
mCherry and eGFP expression to equal measure in a restricted region of the developing pectoral fin (PF), coinciding with the expression domain of both shha
and shhb in the developing pectoral fin (c). The Mut(A) allele drives expression at an additional site on the opposite edge of the fin. The ectopic expression
(arrowheads) is increased by 96 hpf. The double-headed arrow indicates the anterior (a)—posterior (p) axial plane of the developing pectoral fin. (B)
PAX6-SIMO. (a) The regulatory landscape of PAX6, depicting the location of SIMO enhancer. The conservation plot on the right shows the presence of
sequence conservation for SIMO in the zebrafish genome. (b) PAX6-SIMO enhancer-driven reporter expression is shown at 72 hpf. In contrast to theWt(G)
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element, and irrespective of the fluorophore used, the Mut(T) allele consistently fails to drive reporter gene expression in the developing lens (L). (c) RNA in
situ hybridisation analysis of zebrafish pax6a at 72hpf showing the endogenous pax6a expression pattern in the developing eye with strong retinal expression
and weaker lens expression overlapping with the reporter domain driven by theWt(G). Wt: wild-type; Mut: mutant; hpf: hours post fertilization.
doi:10.1371/journal.pgen.1005193.g003
Fig 4. Dual-fluorescence transgenic analysis of IRF6 enhancer MCS-9.7 where a SNP (rs642961, G>A) in a TFAP2A (AP2α) binding site has been
associated with cleft lip. (A) Regulatory landscape of IRF6, depicting the location of MCS-9.7 enhancer. The conservation plot on the right shows the
absence of sequence conservation for MCS-9.7 in the zebrafish genome. (B) IRF6-MCS-9.7 enhancer-driven F1 reporter transgenics. TheWt(G) allele
drives expression in the first pharyngeal arch (PA1) (arrow) and in the developing ethmoid plate (EP) (curved arrow). Mut(A) has lost EP expression but
maintains PA1 expression. (C) RNA in situ hybridisation analysis of zebrafish irf6 at 72hpf showing overlap of the reporter gene expression domain driven by
Wt(G) allele with the endogenous irf6 expression pattern in the developing jaw. Wt: wild-type; Mut: mutant; hpf: hours post fertilization.
doi:10.1371/journal.pgen.1005193.g004
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by micrognathia (mandibular hypoplasia), glossoptosis, and incomplete midline fusion of the
palatal shelves typically leading to a U-shaped cleft palate. These features are thought to result
as a causally linked sequence of developmental malformations arising from a primary deficien-
cy in mandibular growth in early facial development. PRS often occurs as a component of
Campomelic Dysplasia (CD;MIM114290), a syndrome affecting multiple tissues including car-
tilage, testes, notochord, neural crest, inner ear and the central nervous system. CD is caused
by heterozygous loss-of-function coding mutations in the SOX9 gene. In addition, a further
group of CD cases result from disruption of regulatory control of SOX9. PRS can be considered
an endo-phenotype of CD, caused by tissue-specific loss of full gene activity [17]. Detailed ge-
netic analysis of a small set of PRS patients had identified a locus for isolated PRS at ~1.2–1.5
Mb upstream of SOX9 [18], which has been refined using further patient studies [7]. Putative
craniofacial regulatory elements potentially relevant to PRS etiology were identified in this re-
gion through a combination of sequence conservation (at least 70% identity over 300 bp be-
tween human, opossum and chick—the hoc elements), and by p300 ChIP profiling in mouse
craniofacial tissue [7,19]. Sanger sequencing of eleven of the identified elements (Table 2) in a
cohort of 69 individuals, mostly with isolated PRS, identified potentially causative private vari-
ants, not present in dbSNP137, in six of the elements studied. The genomic positions of the
variant nucleotides in these elements, each showing considerable to high evolutionary conser-
vation (as indicated by their GERP scores) (except for PRS135), and potential TF binding sites
affected, are displayed in S2 Table. None of the identified variants could be shown to have aris-
en de novo in the patients; in two cases no parents were available for testing. The family pedi-
grees of the patients are shown in S4 Fig, with the sequenced individual arrowed and other
identified carriers of the mutant allele noted. Incomplete penetrance and variable expressivity
was observed in all the families studied.
We analysed five of the newly identified putative PRS associated CREs (Table 2) using our
zebrafish assay, to establish potential enhancer function in plausible disease-related tissues that
would be affected by the private SNVs in the PRS families (Figs 5 and 6). Remarkably, each of
the tested CREs drives expression in specific craniofacial structures during development
(Table 2 and S1 Table). Each element drives a distinct pattern, significantly overlapping with
the overall expression pattern of sox9 in zebrafish embryonic development (Figs 5D, 6D and
6E), and also with clear overlap between some of the elements.
We found that the PRS associated variants affect expression patterns in a variety of ways. El-
ement p300-PK19 drives expression in the pharyngeal arches, midbrain, otic vesicle and ciliary
margin zone of the eye. We observed the distinct tissue-specific loss of enhancer activity in
pharyngeal arches 1–5 and in the midbrain of the Mut(A) allele of this element at 48 hpf (Fig
5B). However, expression was unaffected in the otic vesicle and the ciliary margin zone. Hoc-
CNE-A drives extensive expression at major sites involved in the developing craniofacial appa-
ratus of zebrafish embryos. At two different stages of development (72hpf and 96hpf), the Wt
(C) allele shows expression in the palatoquadrate, ceratohyals, hyposymplectic, ceratobran-
chials and olfactory placodes. The Mut(T) allele however failed to drive expression in almost
all the craniofacial tissues, partly retaining expression only in the palatoquadrate and olfactory
placodes (Fig 5C).
We also observed temporal (and spatial) changes in tissue-specific CRE activity due to the
presence of PRS-associated variants in another of the CREs (Fig 6A). P300-PK17 showed re-
porter expression in the first pharyngeal arch at 48 and 72 hpf. Expression driven by the mu-
tant allele was present in the first pharyngeal arch at 48 hpf, but almost completely lost by 72
hpf. At 96 hpf reporter signal is seen in Meckel’s cartilage and the palatoquadrate in the wild-
type but these sites are lost in the mutant (Fig 6A).
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Fig 5. Characterisation of novel enhancers from the SOX9 genomic region with PRS-associated point mutations: spatial loss of expression. (A)
Regulatory landscape of SOX9, depicting the location and sequence conservation across evolution for the novel SOX9 enhancers. (B) p300-PK19: Lateral
and ventral views of F1 dual-fluorescence reporter transgenic embryos at 48 hpf. TheWt(G) allele drives expression in the region around the oral cavity (OC),
pharyngeal arches (PA2-5), otic vesicle (OV), ciliary margin zone (CMZ) of the eye, and midbrain (MB). The Mut(A) allele has lost expression in the region
around the oral cavity and pharyngeal arches (curved white arrow) and the midbrain (white arrow). (C) hoc-CNE-A: F1 dual-fluorescence reporter transgenic
embryos at 72 hpf and 96 hpf. At 72 hpf the Wt(C) allele drives expression in the olfactory placodes (OP), and in the palatoquadrate (PQ), ceratohyal (CH),
ceratobranchial (CB) (weak) and hyosymplectic (HS) cartilages. The Mut(T) allele has lost PQ, CH, CB and HS expression; OP expression is retained. At 96
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The final two CREs also revealed distinct craniofacial expression patterns in reporter trans-
genic embryos. However, for these elements we observed no differences in CRE activities be-
tween the wild-type and variant alleles (Fig 6B and 6C). Hoc-CNE-D was shown to drive
expression in the ceratobranchials at two different stages of embryonic development (72 and
96 hpf) and showed additional sites of expression in the olfactory placodes and brain (Fig 6B).
These sites of expression were also seen with the variant allele. The p300-PK22 construct
showed expression at the base of the oral cavity with both the wild-type and the variant con-
struct (Fig 6C). Thus our assay revealed craniofacial expression patterns for all five predicted
CREs from the defined PRS region far upstream of SOX9, and altered spatiotemporal expres-
sion for three of these elements when carrying a sequence variant seen in patients with Pierre
Robin Sequence.
Discussion
The importance of intact gene regulation for correct development and homeostasis has become
increasingly recognised. As a result, research groups interested in understanding the aetiology
and causative mechanisms of human disorders or disease susceptibility are now routinely look-
ing for possible mutations or variations in CREs in patient cohorts, especially in cases where
convincing causative mutations could not be found in the coding regions of genes. However,
the lack of efficient and physiologically relevant assays to functionally validate the consequence
of these sequence changes and to distinguish disease-linked changes from background se-
quence variation is hampering the translation of knowledge about human genetic variation
into an understanding of disease mechanisms. CRE activity is highly dependent on the avail-
ability of the right combination and stoichiometry of specific transcription factors. Conse-
quently, high-throughput assays for assessing the potential effects of disease-associated SNPs
in cultured cells are largely uninformative as they often lack the relevant and necessary biologi-
cal context for tissue or cell-type specific CRE function. In future, cell lines reflecting more
closely the cell phenotypes of developing tissues may become available through emerging stem
cell differentiation protocols [20]. A few high-throughput in vivo assays, such as hydrodynamic
tail-vein injection and retina explant assays [21–23] have also recently been developed but
their application is restricted to CREs functional only in liver or retina respectively. Therefore
there is a pressing need for robust, widely applicable, relatively high-throughput, cost effective
and animal-number efficient in vivo assays that enable the unambiguous comparison of puta-
tive mutant and wild-type alleles of CREs for spatial and temporal differences in activity. Such
screens are vital for differentiating between common, background sequence variation and func-
tionally active, disease-associated mutations in CREs, and will enable rapid prioritization of
candidates for functional follow-up studies.
The novel dual-colour zebrafish reporter transgenic assay pipeline that we have developed
for investigating the functional consequences of disease- and disease-risk associated CRE mu-
tations is designed to incorporate many of the above described merits, and thus will be a valu-
able tool for analysing effects of CRE mutations identified in patient cohorts and GWAS
studies. While we cannot control for the number and position of transgene insertion sites in
our assay, multiple independent transgenic lines bearing both the Wt and Mut version of the
element driving distinct fluorescent reporters in the same animal can rapidly be constructed
and tested, creating a clear consensus activity pattern and minimising the chance of bias in the
hpf the Wt(C) allele drives expression in PQ, CH, CB. The Mut(T) allele has lost CH and CB expression, but retains reduced PQ expression. (D) RNA in situ
hybridisation analysis of zebrafish sox9a at 48–96hpf showing overlap of reporter expression driven by the p300-Pk19Wt(G) and hoc-CNE-AWt(C) alleles
with the endogenous sox9a expression pattern in the developing jaw. Wt: wild-type; Mut: mutant; hpf: hours post fertilization.
doi:10.1371/journal.pgen.1005193.g005
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Fig 6. New enhancers from the SOX9 region with PRS-associated single nucleotide variants. (A) p300-PK17, spatiotemporally altered expression: F1
dual-fluorescence reporter transgenic embryos shown at 48, 72 and 96 hpf. At 48 and 72 hpf theWt(G) allele drives expression in the region around the oral
cavity (OC) (white arrowhead). At 96 hpf Wt(G) drives expression in the palatoquadrate (PQ) (curved white arrow) and Meckel’s cartilage (MC) (open arrow).
The Mut(A) allele is able to drive OC expression at 48 hpf, but this is lost by 72 hpf and at 96 hpf no PQ and MC expression is observed. (B) hoc-CNE-D,
tissue-specific CRE with unaltered expression: F1 dual-fluorescence transgenic embryos at 72 and 96 hpf. TheWt(T) and the Mut(C) alleles both drive
expression in olfactory placode (OP), brain (BR), and ceratobranchials (CB). (C) p300-PK22, craniofacial CRE with unaltered expression: F1 dual-
fluorescence transgenic embryos at 72 hpf. TheWt(A) and Mut(C) allele both drive expression in the region around the oral cavity (OC). (D-E)RNA in situ
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analysis introduced by position effects due to site of integration of the transgenes. Other meth-
ods aimed towards targeted integration of transgenes in pre-defined docking sites in the zebra-
fish [24–27] or medaka [28] genomes are being developed, but the use of these techniques is
more cumbersome and requires the maintenance of specialized fish stocks. Moreover, while
targeted integration offers the advantage of avoiding bias from position effects, the use of dual-
colour transgenesis is currently not established in these assays, complicating the possibility of
simultaneous visualisation of CRE activity in the same animal, and precluding truly detailed as-
sessment of differences in CRE activity. A comprehensive comparison of the merits and limita-
tions of our assay with other available reporter transgenic assays for testing enhancer function
is provided in S3 Table. We anticipate that it will become possible to combine advantages of
the different methods in future assay designs.
Characterisation of detailed expression patterns driven by particular elements allows selec-
tion of the most likely candidate sequences by virtue of their expression in the relevant anatom-
ical structures. In combination with information on the expression patterns of the genes
located within the relevant genomic region this can also help to find the likely target gene of an
enhancer. This can otherwise be problematic as target genes of enhancers are often not simply
the nearest one in the genome, but can be found hundreds or even thousands of kb away in ei-
ther direction, beyond intervening non-target genes, and may reside within the introns of
other non-target genes [29, 30]. Most importantly our method enables the characterisation of
wild-type and mutant variants of the same enhancer in the same individual animal. This is an
important benefit for assessment of more subtle spatio-temporal differences as it allows a direct
comparison without the need for extrapolation between separate individuals.
Disruption of cis-regulatory control of gene expression can occur via a number of distinct
mechanisms [31]. These range from gross changes such as CRE deletion or translocations that
separate the target gene from the influence of the CRE, to single nucleotide change in CREs that
abrogate TF binding, or create novel binding sites. Although our method is suitable for a rapid
screening of candidate regulatory sequences located in any small- to medium-sized region of in-
terest that has been defined by deletion or translocation breakpoint mapping, the power of our
analysis pipeline lies mostly in the characterisation of single nucleotide enhancer variants. We
have therefore focussed on the latter mechanism, and our results indicate that it can be further
subdivided based on the functional consequences of the basepair change. We observe at least
four different types of effect on enhancer activity by patient mutant alleles. The first is the
change in activity in the spatial dimension; this can manifest as complete loss of expression in a
specific tissue (PAX6-SIMO, SOX9-hocCNEA), reduction in the extent of the expression do-
main (the SHH-SBE2 element), or an increase in expression domain (the SHH-ZRS). In the
case of the SBE2 enhancer it had been shown that the reduction in expression domain size is
caused by disruption of a SIX3 binding site in the element [9] and we replicated this effect by
morpholino knock-down of Six3. This experiment demonstrates the modular nature of CREs:
Six3 is not essential for all of the activity of SBE2 as expression in the caudal part of the hypo-
thalamus remains, but Six3 is essential for the expression in the rostral hypothalamus.
The second mechanism we identify is a partial loss of activity in the temporal dimension, as
exemplified by the p300-pk17 element in patient PRS026 which loses expression in the oral
cavity only at later developmental stage. This indicates that the element functions normally
when it first becomes activated, but fails to maintain its activity subsequently. The third
hybridisation analysis of zebrafish sox9a and sox9b at 72hpf and 96hpf, showing overlap of reporter gene expression driven by the p300-Pk17, hoc-CNE-D
and p300-Pk22 elements with the endogenous sox9a and sox9b expression pattern in the developing jaw. Wt: wild-type; Mut: mutant; hpf: hours
post fertilization.
doi:10.1371/journal.pgen.1005193.g006
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example is the complete loss of functional activity of the element in our assay. This suggests the
mutation disrupts the binding of an essential factor potentially affecting the effective formation
of a TF complex, or enhanceosome [32] at the enhancer. The fourth type of outcome is an ap-
parent lack of change, whereby the tissue-specific activity of the enhancer in the appropriate
tissue is unaffected by the sequence variant. The causal connection to the disease phenotype in
such cases is not obvious. The mutation could affect the precise level of transcriptional output
from the element, which is not readily measured in the current fluorescent reporter assay, or it
could disrupt some other function of the element not assayed here, for instance in organisation
of chromatin conformation of the locus [33].
Even though not guaranteed to work for all enhancers, our results show that the dual report-
er transgenic zebrafish assay is a suitable model system to test enhancer activity of many
human disease-associated elements even when the element is not obviously conserved in zebra-
fish itself. Evolution is characterised by variable loss and gain of cis-regulatory sequences [34].
Teleost fish in particular appear to have been subject to an enhanced rate of evolutionary diver-
gence due to the additional whole genome duplication (3R) that occurred at the base of the tel-
eost lineage [35, 36], and consequently the zebrafish genome lacks many of the CNEs
identifiable in other vertebrate species. However, it is likely that this increased divergence has
occurred primarily at the level of the cis-regulatory sequences themselves, while the transcrip-
tional machinery involved in the reading of the elements remains largely conserved due to se-
lection against the wide-ranging effects of changes in the pleiotropic functions of transcription
factors. Our results indicate that human regulatory elements implicated in disease can be tested
in zebrafish with confidence.
It is remarkable that single nucleotide changes at such large genomic distance from their tar-
get gene can have such profound phenotypic effects. Most of the currently known examples of
distal cis-elements involved in genetic disease act as enhancers for genes sensitive to haplo-in-
sufficiency [31]. Our demonstration that single basepair mutations in multiple long-range cis-
elements, with subtly different expression patterns, can lead to PRS highlights the sensitivity of
craniofacial development to correct expression levels of SOX9. The same is true for the other
genes, SHH and IRF6, for which enhancers were tested in this report.
Several of the enhancer variants described here are either inherited or even occur as rare
SNPs in the wider population. Nevertheless we present strong evidence that these variants af-
fect the function of the regulatory element in which they occur. Mutations in enhancers may
not always lead to clear, fully penetrant phenotypes, but rather could contribute partly to a phe-
notype in specific individuals, depending on the presence of other modifier alleles. Incomplete
penetrance may be observed for a number of reasons including variation in expressivity from
the enhancer, or redundancy or buffering among multiple enhancers.
The mufti-faceted assay we have described here allows for the functional characterisation of
disease-associated enhancer variants at the highest throughput that can currently be achieved
using an in vivo animal model system. We anticipate that our strategy will facilitate the analysis
of non-coding variants in genome-wide association study (GWAS) hits, and can also be used
in studying the mechanistic basis for enhancer activity, the engineering of enhancers with de-
sired properties, or to drive highly spatio-temporally specific expression of genetic tools.
Materials and Methods
Ethics statement
All zebrafish experiments were approved by the University of Edinburgh ethical committee
and performed under UK Home Office license number PIL 60/12763; PPL 60/4418.
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Cloning of cis-regulatory elements for generating Tol2 constructs
CREs selected for analysis in transgenic reporter assays were cloned by PCR amplification of
the fragment containing it plus flanking sequence from genomic DNA, using Phusion high fi-
delity polymerase (NEB). attB4 and attB1r sequences were included in the PCR primers for use
with the Gateway recombination cloning system (Invitrogen). The amplified fragment was first
cloned into the Gateway pP4P1r entry vector and sequenced using M13 forward and reverse
primers for verification. In cases where a point mutation was engineered in the wildtype CRE,
a site-directed mutagenesis kit (QuikChange II XL Site-Directed Mutagenesis Kit, Agilent) was
used on the pP4P1r vector containing the wildtype CRE sequence. Test elements in the pP4P1r
vector were combined with a pDONR221 construct containing either a gata2 promoter-eGFP-
polyA or a gata2 promoter mCherry- polyA cassette, and recombined into a destination vector
with a Gateway R4-R2 cassette flanked by Tol2 recombination sites [8, 37]. The primer se-
quences used for amplification of the published CREs described in the manuscript are listed in
S4 Table and images from independent lines for some of the constructs are presented in S1 Fig.
Patient sequencing
Purification of genomic DNA from blood lymphocytes and Sanger sequencing of non-coding
elements upstream of SOX9 was performed according to standard protocols, using the primers
listed in S4 Table.
CRE sequence conservation
Sequence conservation of disease associated CREs was assessed by multiple sequence alignment
and visualised using the VISTA or ECR Browser with the human hg19 sequence as base ge-
nome [38, 39].
Generation of zebrafish transgenic lines
Zebrafish were maintained in a recirculating water system according to standard protocol [40].
Embryos were obtained by breeding adult fish of standard stains (AB andWIK) and raised at
28.5°C as described [40]. Embryos were staged by hours post fertilization (hpf) as described
[41]. Reporter plasmids were isolated using Qiagen miniprep columns and were given extra pu-
rification via a Qiagen PCR purification column (Qiagen), and diluted to 50 ng/microliter with
DNAse/RNAse free water. tol2 transposase RNA was synthesized from a NotI-linearized
pCS2-TP plasmid [42] using the SP6 mMessage mMachine kit (Ambion), and similarly diluted
to 50 ng/microliter. Equal volumes of the reporter construct(s) and the transposase RNA were
mixed immediately prior to injections. 1–2 nl of the solution was micro-injected per embryo of
up to 200 embryos at the 1- to 2-cell stage. Embryos were screened for mosaic fluorescence at
1–5 days post-fertilization i.e. 24–120 hpf (hours post fertilization) and raised to adulthood.
Germline transmission was identified by mating of sexually mature adults to wild-type fish and
examining their progeny for fluorescence. F1 embryos from 3–5 F0 lines showing the best rep-
resentative expression pattern for each construct were selected for confocal imaging. A few pos-
itive embryos were also raised to adulthood and F1 lines were maintained by outcrossing. A
summary of the number of independent lines analyzed for each construct and their expression
sites is included in S1 Table.
Imaging of zebrafish reporter transgenic embryos
Embryos for imaging were treated with 0.003% PTU (1-phenyl2-thio-urea) from 24 hpf to pre-
vent pigmentation. Embryos selected for imaging were anaesthetized with tricaine and
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mounted in 1% low-melting agarose. Images were taken on a Nikon A1R confocal microscope
and processed using A1R analysis software.
Morpholino knock-down of Six3
A zebrafish Six3 antisense morpholino oligonucleotide (Six3AMO) was obtained from Gene
Tools, LLC, with the following sequence: 5’ GCTCTAAAGGAGACCTGAAAACCAT 3’. This
morpholino has sequence complementary to the highly conserved sequences around the trans-
lation initiation codon of both six3a and six3b, and hence inhibits the function of both zebrafish
six3 genes [11]. As control we used the Gene ToolsLLC standard negative control morpholino:
5’ CCTCTTACCTCAGTTACAATTTATA 3’. The morpholinos were injected into 1 to 2-cell
stage of at least 100 embryos to deliver an approximate amount of 2.5 ng per embryo.
mRNA in situ hybridization
RNA in situ hybridization on fish embryos was performed as previously described [43]. The se-
quences of primers used for synthesis of hybridization probes are listed in S5 Table.
Western blotting
Nuclear extract was prepared from ~100 morpholino injected embryos at 48hpf using NE-PER
Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific, catalogue number 78833).
The extracts were boiled with 30 μL of loading buffer (12.5mM Tris at pH 6.8, 2% SDS, 20%
glycerol, 0.002% bromphenol blue, 10% 2-mercaptoethanol) for 5min and were resolved by
10% SDS-PAGE, transferred to nitrocellulose, incubated with antibody (anti-Six3 antibody
ab139317), and detected by chemiluminescence (Thermo scientific SuperSignal West Femto
Maximum Sensitivity Substrate). The membrane was then re-probed with anti-α-tubulin anti-
body (ab44928) as loading control.
Supporting Information
S1 Fig. Wild type and variant CRE driven transgene expression patterns in F1 embryos ob-
tained from multiple independent stable transgenic lines. Dual reporter fluorescence in
transgenic F1 embryos from multiple additional independent lines for the SHH-SBE2 (A),
SHH-ZRS (B), PAX6-SIMO (C), p300-Pk19 (D) and p300-Pk17 (E) elements. These lines are
independent from the ones shown in the main text. The expression sites that are consistent be-
tween the multiple transgenic lines for each of the CREs are marked. RH: rostral hypothalamus;
CH: caudal hypothalamus; PF: pectoral fin; L: lens; CMZ: ciliary margin zone; OV: otic vesicle;
PA2-5: pharyngeal arch 2–5; OC: oral cavity; PQ: palatoquadrate; MC: Meckel’s cartilage; Wt:
wild-type; Mut: mutant; hpf: hours post fertilization.
(TIF)
S2 Fig. Western blot to confirm morpholino mediated Six3 knockdown. The efficiency of
Six3 depletion in zebrafish embryos injected with Six3 AMOmorpholinos is demonstrated by
Western blotting of protein extract from pooled morpholino-injected embryos with anti-Six3
antibody. The absence of Six3 in the extract from Six3 AMOmorpholino-injected embryos is
highlighted by a black arrow at 32 KDa, while Six3 is present in fish injected with a control
morpholino. After stripping, the blot was incubated with anti-α-tubulin antibody for loading
control (50 kDa, grey arrow).
(TIF)
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S3 Fig. SHH-ZRS in multiple founders. SHH-ZRS enhancer-driven reporter expression is
shown at 72 hpf (A) The Wt(G) allele is shown driving eGFP expression in a restricted region
of the developing pectoral fin (PF) in two independent founders (1 and 2). (B) TheWt(G) allele
is shown driving mCherry expression in a restricted region of the developing pectoral fin (PF)
in four independent founders (1–4). Consistent reporter gene expression was detected only in
the pectoral fin in all independent founders shown.
(TIF)
S4 Fig. Pedigrees for Pierre Robin sequence (PRS) patients harbouring candidate patho-
genic variants in SOX9 non-coding elements. Genotypes are indicated for those individuals
available for sequencing: + wildtype allele,—mutant allele. Probands are indicated with
an arrow.
(TIF)
S1 Table. Wild type and variant CRE driven transgene expression sites in F1 embryos ob-
tained from multiple independent stable transgenic F0 lines.
(DOCX)
S2 Table. Candidate pathogenic variants identified in conserved non-coding elements with-
in the PRS-region upstream of SOX9 in PRS patients.
(DOCX)
S3 Table. Summary of pros and cons of the dual-colour zebrafish reporter transgenic CRE
assay versus PhiC31-integrase mediated targeted integration assays.
(DOCX)
S4 Table. Primers used to prepare the CRE constructs.
(DOCX)
S5 Table. Primers used to prepare the probes for RNA in situ hybridisation.
(DOCX)
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